According to Teva Pharmaceutical Industries's latest financial reports the company has a price-to-book ratio of 1.88.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 1.46 | 23.76% |
2022-12-31 | 1.18 | 49.93% |
2021-12-31 | 0.7858 | -16.53% |
2020-12-31 | 0.9414 | 31.42% |
2019-12-31 | 0.7163 | -33.31% |
2018-12-31 | 1.07 | 4.49% |
2017-12-31 | 1.03 | -2.23% |
2016-12-31 | 1.05 | -46.82% |
2015-12-31 | 1.98 | -4.91% |
2014-12-31 | 2.08 | 39.29% |
2013-12-31 | 1.49 | 7.19% |
2012-12-31 | 1.39 | -12.68% |
2011-12-31 | 1.60 | -24.99% |
2010-12-31 | 2.13 | -17.67% |
2009-12-31 | 2.58 | 11.69% |
2008-12-31 | 2.31 | -15.27% |
2007-12-31 | 2.73 | 23.77% |
2006-12-31 | 2.21 | -52.03% |
2005-12-31 | 4.60 | 32.62% |
2004-12-31 | 3.47 | -27.44% |
2003-12-31 | 4.78 | -12.25% |
2002-12-31 | 5.44 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Novartis NVS | 4.28 | 127.39% | ๐จ๐ญ Switzerland |
Pfizer PFE | 1.61 | -14.50% | ๐บ๐ธ USA |
Sanofi SNY | 1.48 | -21.53% | ๐ซ๐ท France |
Merck MRK | 8.82 | 369.13% | ๐บ๐ธ USA |
AstraZeneca AZN | 5.92 | 214.94% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | 5.15 | 173.70% | ๐ฌ๐ง UK |
Dr. Reddy's RDY | 3.88 | 106.15% | ๐ฎ๐ณ India |